TRV GP IV, LLC
- SEC CIK
- 0001688325
- Latest filing
- Aug 7, 2026
Holdings in Q2 2022
Holdings as of Jun 30, 2022, filed Aug 12, 2022. Long positions only; changes compare share counts with Q1 2022.
- Positions
- 5
- 0 vs. Q1 2022
- Portfolio value
- $152.1M
- −$120.9M (−44.3%) vs. Q1 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| TNGXTango Therapeutics, Inc. | COM | 19,363,975 | $87.7M | 57.7% | 00.0% | Unchanged | History |
| RVMDRevolution Medicines, Inc. | COM | 1,419,900 | $27.7M | 18.2% | 00.0% | Unchanged | History |
| PLRXPliant Therapeutics, Inc. | COM | 2,132,867 | $17.1M | 11.2% | 00.0% | Unchanged | History |
| FULCFulcrum Therapeutics, Inc. | COM | 2,343,154 | $11.5M | 7.5% | 00.0% | Unchanged | History |
| DNTHDianthus Therapeutics, Inc. | COM | 6,758,204 | $8.11M | 5.3% | 00.0% | Unchanged | History |